Global Non-recombinant Coagulation Factors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Non-recombinant Coagulation Factors market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.
The Global Info Research report includes an overview of the development of the Non-recombinant Coagulation Factors industry chain, the market status of Hemophilia (Coagulation Factor VIII, Human Fibrinogen), Fibrinogen Deficiency (Coagulation Factor VIII, Human Fibrinogen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-recombinant Coagulation Factors.
Regionally, the report analyzes the Non-recombinant Coagulation Factors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-recombinant Coagulation Factors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-recombinant Coagulation Factors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-recombinant Coagulation Factors industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Coagulation Factor VIII, Human Fibrinogen).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-recombinant Coagulation Factors market.
Regional Analysis: The report involves examining the Non-recombinant Coagulation Factors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-recombinant Coagulation Factors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-recombinant Coagulation Factors:
Company Analysis: Report covers individual Non-recombinant Coagulation Factors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-recombinant Coagulation Factors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hemophilia, Fibrinogen Deficiency).
Technology Analysis: Report covers specific technologies relevant to Non-recombinant Coagulation Factors. It assesses the current state, advancements, and potential future developments in Non-recombinant Coagulation Factors areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-recombinant Coagulation Factors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-recombinant Coagulation Factors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Non-recombinant Coagulation Factors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-recombinant Coagulation Factors, with price, sales, revenue and global market share of Non-recombinant Coagulation Factors from 2018 to 2023.
Chapter 3, the Non-recombinant Coagulation Factors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-recombinant Coagulation Factors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-recombinant Coagulation Factors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-recombinant Coagulation Factors.
Chapter 14 and 15, to describe Non-recombinant Coagulation Factors sales channel, distributors, customers, research findings and conclusion.
Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.
The Global Info Research report includes an overview of the development of the Non-recombinant Coagulation Factors industry chain, the market status of Hemophilia (Coagulation Factor VIII, Human Fibrinogen), Fibrinogen Deficiency (Coagulation Factor VIII, Human Fibrinogen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-recombinant Coagulation Factors.
Regionally, the report analyzes the Non-recombinant Coagulation Factors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-recombinant Coagulation Factors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-recombinant Coagulation Factors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-recombinant Coagulation Factors industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Coagulation Factor VIII, Human Fibrinogen).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-recombinant Coagulation Factors market.
Regional Analysis: The report involves examining the Non-recombinant Coagulation Factors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-recombinant Coagulation Factors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-recombinant Coagulation Factors:
Company Analysis: Report covers individual Non-recombinant Coagulation Factors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-recombinant Coagulation Factors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hemophilia, Fibrinogen Deficiency).
Technology Analysis: Report covers specific technologies relevant to Non-recombinant Coagulation Factors. It assesses the current state, advancements, and potential future developments in Non-recombinant Coagulation Factors areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-recombinant Coagulation Factors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-recombinant Coagulation Factors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Coagulation Factor VIII
- Human Fibrinogen
- Others
- Hemophilia
- Fibrinogen Deficiency
- Other
- Takeda Pharmaceutical
- Instituto Grifols SA
- CSL Behring LLC
- KM Biologics KK
- Baxter Healthcare Corp.
- Sanquin
- Johnson & Johnson
- Octapharma AG
- Bio Products Laboratory Ltd.
- Grifols Biologicals, Inc.
- Pfizer Inc.
- Intas Biopharmaceuticals Ltd.
- Shandong Taibang Biological Products
- Sinopharm Group Shanghai Blood Products
- SHANGHAI RAAS
- China Resources Boya Bio-Pharmaceutical
- Chengdu Rongsheng Pharmaceuticals
- Yuanda Shuyang Pharmaceutical
- HUALAN BIO
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Non-recombinant Coagulation Factors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-recombinant Coagulation Factors, with price, sales, revenue and global market share of Non-recombinant Coagulation Factors from 2018 to 2023.
Chapter 3, the Non-recombinant Coagulation Factors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-recombinant Coagulation Factors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-recombinant Coagulation Factors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-recombinant Coagulation Factors.
Chapter 14 and 15, to describe Non-recombinant Coagulation Factors sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-recombinant Coagulation Factors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-recombinant Coagulation Factors Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Coagulation Factor VIII
1.3.3 Human Fibrinogen
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-recombinant Coagulation Factors Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hemophilia
1.4.3 Fibrinogen Deficiency
1.4.4 Other
1.5 Global Non-recombinant Coagulation Factors Market Size & Forecast
1.5.1 Global Non-recombinant Coagulation Factors Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-recombinant Coagulation Factors Sales Quantity (2018-2029)
1.5.3 Global Non-recombinant Coagulation Factors Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Takeda Pharmaceutical
2.1.1 Takeda Pharmaceutical Details
2.1.2 Takeda Pharmaceutical Major Business
2.1.3 Takeda Pharmaceutical Non-recombinant Coagulation Factors Product and Services
2.1.4 Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Pharmaceutical Recent Developments/Updates
2.2 Instituto Grifols SA
2.2.1 Instituto Grifols SA Details
2.2.2 Instituto Grifols SA Major Business
2.2.3 Instituto Grifols SA Non-recombinant Coagulation Factors Product and Services
2.2.4 Instituto Grifols SA Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Instituto Grifols SA Recent Developments/Updates
2.3 CSL Behring LLC
2.3.1 CSL Behring LLC Details
2.3.2 CSL Behring LLC Major Business
2.3.3 CSL Behring LLC Non-recombinant Coagulation Factors Product and Services
2.3.4 CSL Behring LLC Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CSL Behring LLC Recent Developments/Updates
2.4 KM Biologics KK
2.4.1 KM Biologics KK Details
2.4.2 KM Biologics KK Major Business
2.4.3 KM Biologics KK Non-recombinant Coagulation Factors Product and Services
2.4.4 KM Biologics KK Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 KM Biologics KK Recent Developments/Updates
2.5 Baxter Healthcare Corp.
2.5.1 Baxter Healthcare Corp. Details
2.5.2 Baxter Healthcare Corp. Major Business
2.5.3 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product and Services
2.5.4 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Baxter Healthcare Corp. Recent Developments/Updates
2.6 Sanquin
2.6.1 Sanquin Details
2.6.2 Sanquin Major Business
2.6.3 Sanquin Non-recombinant Coagulation Factors Product and Services
2.6.4 Sanquin Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanquin Recent Developments/Updates
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Non-recombinant Coagulation Factors Product and Services
2.7.4 Johnson & Johnson Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson & Johnson Recent Developments/Updates
2.8 Octapharma AG
2.8.1 Octapharma AG Details
2.8.2 Octapharma AG Major Business
2.8.3 Octapharma AG Non-recombinant Coagulation Factors Product and Services
2.8.4 Octapharma AG Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Octapharma AG Recent Developments/Updates
2.9 Bio Products Laboratory Ltd.
2.9.1 Bio Products Laboratory Ltd. Details
2.9.2 Bio Products Laboratory Ltd. Major Business
2.9.3 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product and Services
2.9.4 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bio Products Laboratory Ltd. Recent Developments/Updates
2.10 Grifols Biologicals, Inc.
2.10.1 Grifols Biologicals, Inc. Details
2.10.2 Grifols Biologicals, Inc. Major Business
2.10.3 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product and Services
2.10.4 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Grifols Biologicals, Inc. Recent Developments/Updates
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Non-recombinant Coagulation Factors Product and Services
2.11.4 Pfizer Inc. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc. Recent Developments/Updates
2.12 Intas Biopharmaceuticals Ltd.
2.12.1 Intas Biopharmaceuticals Ltd. Details
2.12.2 Intas Biopharmaceuticals Ltd. Major Business
2.12.3 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product and Services
2.12.4 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Intas Biopharmaceuticals Ltd. Recent Developments/Updates
2.13 Shandong Taibang Biological Products
2.13.1 Shandong Taibang Biological Products Details
2.13.2 Shandong Taibang Biological Products Major Business
2.13.3 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product and Services
2.13.4 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shandong Taibang Biological Products Recent Developments/Updates
2.14 Sinopharm Group Shanghai Blood Products
2.14.1 Sinopharm Group Shanghai Blood Products Details
2.14.2 Sinopharm Group Shanghai Blood Products Major Business
2.14.3 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product and Services
2.14.4 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sinopharm Group Shanghai Blood Products Recent Developments/Updates
2.15 SHANGHAI RAAS
2.15.1 SHANGHAI RAAS Details
2.15.2 SHANGHAI RAAS Major Business
2.15.3 SHANGHAI RAAS Non-recombinant Coagulation Factors Product and Services
2.15.4 SHANGHAI RAAS Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 SHANGHAI RAAS Recent Developments/Updates
2.16 China Resources Boya Bio-Pharmaceutical
2.16.1 China Resources Boya Bio-Pharmaceutical Details
2.16.2 China Resources Boya Bio-Pharmaceutical Major Business
2.16.3 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product and Services
2.16.4 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 China Resources Boya Bio-Pharmaceutical Recent Developments/Updates
2.17 Chengdu Rongsheng Pharmaceuticals
2.17.1 Chengdu Rongsheng Pharmaceuticals Details
2.17.2 Chengdu Rongsheng Pharmaceuticals Major Business
2.17.3 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product and Services
2.17.4 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Chengdu Rongsheng Pharmaceuticals Recent Developments/Updates
2.18 Yuanda Shuyang Pharmaceutical
2.18.1 Yuanda Shuyang Pharmaceutical Details
2.18.2 Yuanda Shuyang Pharmaceutical Major Business
2.18.3 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product and Services
2.18.4 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Yuanda Shuyang Pharmaceutical Recent Developments/Updates
2.19 HUALAN BIO
2.19.1 HUALAN BIO Details
2.19.2 HUALAN BIO Major Business
2.19.3 HUALAN BIO Non-recombinant Coagulation Factors Product and Services
2.19.4 HUALAN BIO Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 HUALAN BIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-RECOMBINANT COAGULATION FACTORS BY MANUFACTURER
3.1 Global Non-recombinant Coagulation Factors Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-recombinant Coagulation Factors Revenue by Manufacturer (2018-2023)
3.3 Global Non-recombinant Coagulation Factors Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-recombinant Coagulation Factors by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-recombinant Coagulation Factors Manufacturer Market Share in 2022
3.4.2 Top 6 Non-recombinant Coagulation Factors Manufacturer Market Share in 2022
3.5 Non-recombinant Coagulation Factors Market: Overall Company Footprint Analysis
3.5.1 Non-recombinant Coagulation Factors Market: Region Footprint
3.5.2 Non-recombinant Coagulation Factors Market: Company Product Type Footprint
3.5.3 Non-recombinant Coagulation Factors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-recombinant Coagulation Factors Market Size by Region
4.1.1 Global Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2029)
4.1.2 Global Non-recombinant Coagulation Factors Consumption Value by Region (2018-2029)
4.1.3 Global Non-recombinant Coagulation Factors Average Price by Region (2018-2029)
4.2 North America Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.3 Europe Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.4 Asia-Pacific Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.5 South America Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.6 Middle East and Africa Non-recombinant Coagulation Factors Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
5.2 Global Non-recombinant Coagulation Factors Consumption Value by Type (2018-2029)
5.3 Global Non-recombinant Coagulation Factors Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
6.2 Global Non-recombinant Coagulation Factors Consumption Value by Application (2018-2029)
6.3 Global Non-recombinant Coagulation Factors Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
7.2 North America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
7.3 North America Non-recombinant Coagulation Factors Market Size by Country
7.3.1 North America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
7.3.2 North America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
8.2 Europe Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
8.3 Europe Non-recombinant Coagulation Factors Market Size by Country
8.3.1 Europe Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-recombinant Coagulation Factors Market Size by Region
9.3.1 Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-recombinant Coagulation Factors Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
10.2 South America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
10.3 South America Non-recombinant Coagulation Factors Market Size by Country
10.3.1 South America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
10.3.2 South America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-recombinant Coagulation Factors Market Size by Country
11.3.1 Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Non-recombinant Coagulation Factors Market Drivers
12.2 Non-recombinant Coagulation Factors Market Restraints
12.3 Non-recombinant Coagulation Factors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-recombinant Coagulation Factors and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-recombinant Coagulation Factors
13.3 Non-recombinant Coagulation Factors Production Process
13.4 Non-recombinant Coagulation Factors Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-recombinant Coagulation Factors Typical Distributors
14.3 Non-recombinant Coagulation Factors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Non-recombinant Coagulation Factors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-recombinant Coagulation Factors Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Coagulation Factor VIII
1.3.3 Human Fibrinogen
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-recombinant Coagulation Factors Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hemophilia
1.4.3 Fibrinogen Deficiency
1.4.4 Other
1.5 Global Non-recombinant Coagulation Factors Market Size & Forecast
1.5.1 Global Non-recombinant Coagulation Factors Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-recombinant Coagulation Factors Sales Quantity (2018-2029)
1.5.3 Global Non-recombinant Coagulation Factors Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Takeda Pharmaceutical
2.1.1 Takeda Pharmaceutical Details
2.1.2 Takeda Pharmaceutical Major Business
2.1.3 Takeda Pharmaceutical Non-recombinant Coagulation Factors Product and Services
2.1.4 Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Pharmaceutical Recent Developments/Updates
2.2 Instituto Grifols SA
2.2.1 Instituto Grifols SA Details
2.2.2 Instituto Grifols SA Major Business
2.2.3 Instituto Grifols SA Non-recombinant Coagulation Factors Product and Services
2.2.4 Instituto Grifols SA Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Instituto Grifols SA Recent Developments/Updates
2.3 CSL Behring LLC
2.3.1 CSL Behring LLC Details
2.3.2 CSL Behring LLC Major Business
2.3.3 CSL Behring LLC Non-recombinant Coagulation Factors Product and Services
2.3.4 CSL Behring LLC Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CSL Behring LLC Recent Developments/Updates
2.4 KM Biologics KK
2.4.1 KM Biologics KK Details
2.4.2 KM Biologics KK Major Business
2.4.3 KM Biologics KK Non-recombinant Coagulation Factors Product and Services
2.4.4 KM Biologics KK Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 KM Biologics KK Recent Developments/Updates
2.5 Baxter Healthcare Corp.
2.5.1 Baxter Healthcare Corp. Details
2.5.2 Baxter Healthcare Corp. Major Business
2.5.3 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product and Services
2.5.4 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Baxter Healthcare Corp. Recent Developments/Updates
2.6 Sanquin
2.6.1 Sanquin Details
2.6.2 Sanquin Major Business
2.6.3 Sanquin Non-recombinant Coagulation Factors Product and Services
2.6.4 Sanquin Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanquin Recent Developments/Updates
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Non-recombinant Coagulation Factors Product and Services
2.7.4 Johnson & Johnson Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson & Johnson Recent Developments/Updates
2.8 Octapharma AG
2.8.1 Octapharma AG Details
2.8.2 Octapharma AG Major Business
2.8.3 Octapharma AG Non-recombinant Coagulation Factors Product and Services
2.8.4 Octapharma AG Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Octapharma AG Recent Developments/Updates
2.9 Bio Products Laboratory Ltd.
2.9.1 Bio Products Laboratory Ltd. Details
2.9.2 Bio Products Laboratory Ltd. Major Business
2.9.3 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product and Services
2.9.4 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bio Products Laboratory Ltd. Recent Developments/Updates
2.10 Grifols Biologicals, Inc.
2.10.1 Grifols Biologicals, Inc. Details
2.10.2 Grifols Biologicals, Inc. Major Business
2.10.3 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product and Services
2.10.4 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Grifols Biologicals, Inc. Recent Developments/Updates
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Non-recombinant Coagulation Factors Product and Services
2.11.4 Pfizer Inc. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc. Recent Developments/Updates
2.12 Intas Biopharmaceuticals Ltd.
2.12.1 Intas Biopharmaceuticals Ltd. Details
2.12.2 Intas Biopharmaceuticals Ltd. Major Business
2.12.3 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product and Services
2.12.4 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Intas Biopharmaceuticals Ltd. Recent Developments/Updates
2.13 Shandong Taibang Biological Products
2.13.1 Shandong Taibang Biological Products Details
2.13.2 Shandong Taibang Biological Products Major Business
2.13.3 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product and Services
2.13.4 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shandong Taibang Biological Products Recent Developments/Updates
2.14 Sinopharm Group Shanghai Blood Products
2.14.1 Sinopharm Group Shanghai Blood Products Details
2.14.2 Sinopharm Group Shanghai Blood Products Major Business
2.14.3 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product and Services
2.14.4 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sinopharm Group Shanghai Blood Products Recent Developments/Updates
2.15 SHANGHAI RAAS
2.15.1 SHANGHAI RAAS Details
2.15.2 SHANGHAI RAAS Major Business
2.15.3 SHANGHAI RAAS Non-recombinant Coagulation Factors Product and Services
2.15.4 SHANGHAI RAAS Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 SHANGHAI RAAS Recent Developments/Updates
2.16 China Resources Boya Bio-Pharmaceutical
2.16.1 China Resources Boya Bio-Pharmaceutical Details
2.16.2 China Resources Boya Bio-Pharmaceutical Major Business
2.16.3 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product and Services
2.16.4 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 China Resources Boya Bio-Pharmaceutical Recent Developments/Updates
2.17 Chengdu Rongsheng Pharmaceuticals
2.17.1 Chengdu Rongsheng Pharmaceuticals Details
2.17.2 Chengdu Rongsheng Pharmaceuticals Major Business
2.17.3 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product and Services
2.17.4 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Chengdu Rongsheng Pharmaceuticals Recent Developments/Updates
2.18 Yuanda Shuyang Pharmaceutical
2.18.1 Yuanda Shuyang Pharmaceutical Details
2.18.2 Yuanda Shuyang Pharmaceutical Major Business
2.18.3 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product and Services
2.18.4 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Yuanda Shuyang Pharmaceutical Recent Developments/Updates
2.19 HUALAN BIO
2.19.1 HUALAN BIO Details
2.19.2 HUALAN BIO Major Business
2.19.3 HUALAN BIO Non-recombinant Coagulation Factors Product and Services
2.19.4 HUALAN BIO Non-recombinant Coagulation Factors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 HUALAN BIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-RECOMBINANT COAGULATION FACTORS BY MANUFACTURER
3.1 Global Non-recombinant Coagulation Factors Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-recombinant Coagulation Factors Revenue by Manufacturer (2018-2023)
3.3 Global Non-recombinant Coagulation Factors Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-recombinant Coagulation Factors by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-recombinant Coagulation Factors Manufacturer Market Share in 2022
3.4.2 Top 6 Non-recombinant Coagulation Factors Manufacturer Market Share in 2022
3.5 Non-recombinant Coagulation Factors Market: Overall Company Footprint Analysis
3.5.1 Non-recombinant Coagulation Factors Market: Region Footprint
3.5.2 Non-recombinant Coagulation Factors Market: Company Product Type Footprint
3.5.3 Non-recombinant Coagulation Factors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-recombinant Coagulation Factors Market Size by Region
4.1.1 Global Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2029)
4.1.2 Global Non-recombinant Coagulation Factors Consumption Value by Region (2018-2029)
4.1.3 Global Non-recombinant Coagulation Factors Average Price by Region (2018-2029)
4.2 North America Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.3 Europe Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.4 Asia-Pacific Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.5 South America Non-recombinant Coagulation Factors Consumption Value (2018-2029)
4.6 Middle East and Africa Non-recombinant Coagulation Factors Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
5.2 Global Non-recombinant Coagulation Factors Consumption Value by Type (2018-2029)
5.3 Global Non-recombinant Coagulation Factors Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
6.2 Global Non-recombinant Coagulation Factors Consumption Value by Application (2018-2029)
6.3 Global Non-recombinant Coagulation Factors Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
7.2 North America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
7.3 North America Non-recombinant Coagulation Factors Market Size by Country
7.3.1 North America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
7.3.2 North America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
8.2 Europe Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
8.3 Europe Non-recombinant Coagulation Factors Market Size by Country
8.3.1 Europe Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-recombinant Coagulation Factors Market Size by Region
9.3.1 Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-recombinant Coagulation Factors Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
10.2 South America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
10.3 South America Non-recombinant Coagulation Factors Market Size by Country
10.3.1 South America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
10.3.2 South America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-recombinant Coagulation Factors Market Size by Country
11.3.1 Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-recombinant Coagulation Factors Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Non-recombinant Coagulation Factors Market Drivers
12.2 Non-recombinant Coagulation Factors Market Restraints
12.3 Non-recombinant Coagulation Factors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-recombinant Coagulation Factors and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-recombinant Coagulation Factors
13.3 Non-recombinant Coagulation Factors Production Process
13.4 Non-recombinant Coagulation Factors Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-recombinant Coagulation Factors Typical Distributors
14.3 Non-recombinant Coagulation Factors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-recombinant Coagulation Factors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-recombinant Coagulation Factors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Pharmaceutical Major Business
Table 5. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product and Services
Table 6. Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Takeda Pharmaceutical Recent Developments/Updates
Table 8. Instituto Grifols SA Basic Information, Manufacturing Base and Competitors
Table 9. Instituto Grifols SA Major Business
Table 10. Instituto Grifols SA Non-recombinant Coagulation Factors Product and Services
Table 11. Instituto Grifols SA Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Instituto Grifols SA Recent Developments/Updates
Table 13. CSL Behring LLC Basic Information, Manufacturing Base and Competitors
Table 14. CSL Behring LLC Major Business
Table 15. CSL Behring LLC Non-recombinant Coagulation Factors Product and Services
Table 16. CSL Behring LLC Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CSL Behring LLC Recent Developments/Updates
Table 18. KM Biologics KK Basic Information, Manufacturing Base and Competitors
Table 19. KM Biologics KK Major Business
Table 20. KM Biologics KK Non-recombinant Coagulation Factors Product and Services
Table 21. KM Biologics KK Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. KM Biologics KK Recent Developments/Updates
Table 23. Baxter Healthcare Corp. Basic Information, Manufacturing Base and Competitors
Table 24. Baxter Healthcare Corp. Major Business
Table 25. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product and Services
Table 26. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Baxter Healthcare Corp. Recent Developments/Updates
Table 28. Sanquin Basic Information, Manufacturing Base and Competitors
Table 29. Sanquin Major Business
Table 30. Sanquin Non-recombinant Coagulation Factors Product and Services
Table 31. Sanquin Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanquin Recent Developments/Updates
Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Major Business
Table 35. Johnson & Johnson Non-recombinant Coagulation Factors Product and Services
Table 36. Johnson & Johnson Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Johnson & Johnson Recent Developments/Updates
Table 38. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 39. Octapharma AG Major Business
Table 40. Octapharma AG Non-recombinant Coagulation Factors Product and Services
Table 41. Octapharma AG Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Octapharma AG Recent Developments/Updates
Table 43. Bio Products Laboratory Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Bio Products Laboratory Ltd. Major Business
Table 45. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product and Services
Table 46. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Bio Products Laboratory Ltd. Recent Developments/Updates
Table 48. Grifols Biologicals, Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Grifols Biologicals, Inc. Major Business
Table 50. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product and Services
Table 51. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Grifols Biologicals, Inc. Recent Developments/Updates
Table 53. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc. Major Business
Table 55. Pfizer Inc. Non-recombinant Coagulation Factors Product and Services
Table 56. Pfizer Inc. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Inc. Recent Developments/Updates
Table 58. Intas Biopharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Intas Biopharmaceuticals Ltd. Major Business
Table 60. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product and Services
Table 61. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Intas Biopharmaceuticals Ltd. Recent Developments/Updates
Table 63. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 64. Shandong Taibang Biological Products Major Business
Table 65. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product and Services
Table 66. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shandong Taibang Biological Products Recent Developments/Updates
Table 68. Sinopharm Group Shanghai Blood Products Basic Information, Manufacturing Base and Competitors
Table 69. Sinopharm Group Shanghai Blood Products Major Business
Table 70. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product and Services
Table 71. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sinopharm Group Shanghai Blood Products Recent Developments/Updates
Table 73. SHANGHAI RAAS Basic Information, Manufacturing Base and Competitors
Table 74. SHANGHAI RAAS Major Business
Table 75. SHANGHAI RAAS Non-recombinant Coagulation Factors Product and Services
Table 76. SHANGHAI RAAS Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. SHANGHAI RAAS Recent Developments/Updates
Table 78. China Resources Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. China Resources Boya Bio-Pharmaceutical Major Business
Table 80. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product and Services
Table 81. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. China Resources Boya Bio-Pharmaceutical Recent Developments/Updates
Table 83. Chengdu Rongsheng Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Chengdu Rongsheng Pharmaceuticals Major Business
Table 85. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product and Services
Table 86. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Chengdu Rongsheng Pharmaceuticals Recent Developments/Updates
Table 88. Yuanda Shuyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Yuanda Shuyang Pharmaceutical Major Business
Table 90. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product and Services
Table 91. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Yuanda Shuyang Pharmaceutical Recent Developments/Updates
Table 93. HUALAN BIO Basic Information, Manufacturing Base and Competitors
Table 94. HUALAN BIO Major Business
Table 95. HUALAN BIO Non-recombinant Coagulation Factors Product and Services
Table 96. HUALAN BIO Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. HUALAN BIO Recent Developments/Updates
Table 98. Global Non-recombinant Coagulation Factors Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Non-recombinant Coagulation Factors Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Non-recombinant Coagulation Factors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in Non-recombinant Coagulation Factors, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Non-recombinant Coagulation Factors Production Site of Key Manufacturer
Table 103. Non-recombinant Coagulation Factors Market: Company Product Type Footprint
Table 104. Non-recombinant Coagulation Factors Market: Company Product Application Footprint
Table 105. Non-recombinant Coagulation Factors New Market Entrants and Barriers to Market Entry
Table 106. Non-recombinant Coagulation Factors Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Non-recombinant Coagulation Factors Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Non-recombinant Coagulation Factors Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Non-recombinant Coagulation Factors Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Non-recombinant Coagulation Factors Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global Non-recombinant Coagulation Factors Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Non-recombinant Coagulation Factors Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Non-recombinant Coagulation Factors Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Non-recombinant Coagulation Factors Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global Non-recombinant Coagulation Factors Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Non-recombinant Coagulation Factors Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Non-recombinant Coagulation Factors Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Non-recombinant Coagulation Factors Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Non-recombinant Coagulation Factors Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Non-recombinant Coagulation Factors Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Non-recombinant Coagulation Factors Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Non-recombinant Coagulation Factors Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Non-recombinant Coagulation Factors Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Non-recombinant Coagulation Factors Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Non-recombinant Coagulation Factors Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Non-recombinant Coagulation Factors Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Non-recombinant Coagulation Factors Raw Material
Table 166. Key Manufacturers of Non-recombinant Coagulation Factors Raw Materials
Table 167. Non-recombinant Coagulation Factors Typical Distributors
Table 168. Non-recombinant Coagulation Factors Typical Customers
LIST OF FIGURE
s
Figure 1. Non-recombinant Coagulation Factors Picture
Figure 2. Global Non-recombinant Coagulation Factors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Type in 2022
Figure 4. Coagulation Factor VIII Examples
Figure 5. Human Fibrinogen Examples
Figure 6. Others Examples
Figure 7. Global Non-recombinant Coagulation Factors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Application in 2022
Figure 9. Hemophilia Examples
Figure 10. Fibrinogen Deficiency Examples
Figure 11. Other Examples
Figure 12. Global Non-recombinant Coagulation Factors Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Non-recombinant Coagulation Factors Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Non-recombinant Coagulation Factors Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Non-recombinant Coagulation Factors Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Non-recombinant Coagulation Factors by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Non-recombinant Coagulation Factors Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Non-recombinant Coagulation Factors Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Non-recombinant Coagulation Factors Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Non-recombinant Coagulation Factors Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Non-recombinant Coagulation Factors Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Non-recombinant Coagulation Factors Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Non-recombinant Coagulation Factors Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Non-recombinant Coagulation Factors Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value Market Share by Region (2018-2029)
Figure 54. China Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Non-recombinant Coagulation Factors Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Non-recombinant Coagulation Factors Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Non-recombinant Coagulation Factors Market Drivers
Figure 75. Non-recombinant Coagulation Factors Market Restraints
Figure 76. Non-recombinant Coagulation Factors Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors in 2022
Figure 79. Manufacturing Process Analysis of Non-recombinant Coagulation Factors
Figure 80. Non-recombinant Coagulation Factors Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Table 1. Global Non-recombinant Coagulation Factors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-recombinant Coagulation Factors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Pharmaceutical Major Business
Table 5. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product and Services
Table 6. Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Takeda Pharmaceutical Recent Developments/Updates
Table 8. Instituto Grifols SA Basic Information, Manufacturing Base and Competitors
Table 9. Instituto Grifols SA Major Business
Table 10. Instituto Grifols SA Non-recombinant Coagulation Factors Product and Services
Table 11. Instituto Grifols SA Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Instituto Grifols SA Recent Developments/Updates
Table 13. CSL Behring LLC Basic Information, Manufacturing Base and Competitors
Table 14. CSL Behring LLC Major Business
Table 15. CSL Behring LLC Non-recombinant Coagulation Factors Product and Services
Table 16. CSL Behring LLC Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CSL Behring LLC Recent Developments/Updates
Table 18. KM Biologics KK Basic Information, Manufacturing Base and Competitors
Table 19. KM Biologics KK Major Business
Table 20. KM Biologics KK Non-recombinant Coagulation Factors Product and Services
Table 21. KM Biologics KK Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. KM Biologics KK Recent Developments/Updates
Table 23. Baxter Healthcare Corp. Basic Information, Manufacturing Base and Competitors
Table 24. Baxter Healthcare Corp. Major Business
Table 25. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product and Services
Table 26. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Baxter Healthcare Corp. Recent Developments/Updates
Table 28. Sanquin Basic Information, Manufacturing Base and Competitors
Table 29. Sanquin Major Business
Table 30. Sanquin Non-recombinant Coagulation Factors Product and Services
Table 31. Sanquin Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanquin Recent Developments/Updates
Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Major Business
Table 35. Johnson & Johnson Non-recombinant Coagulation Factors Product and Services
Table 36. Johnson & Johnson Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Johnson & Johnson Recent Developments/Updates
Table 38. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 39. Octapharma AG Major Business
Table 40. Octapharma AG Non-recombinant Coagulation Factors Product and Services
Table 41. Octapharma AG Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Octapharma AG Recent Developments/Updates
Table 43. Bio Products Laboratory Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Bio Products Laboratory Ltd. Major Business
Table 45. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product and Services
Table 46. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Bio Products Laboratory Ltd. Recent Developments/Updates
Table 48. Grifols Biologicals, Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Grifols Biologicals, Inc. Major Business
Table 50. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product and Services
Table 51. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Grifols Biologicals, Inc. Recent Developments/Updates
Table 53. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc. Major Business
Table 55. Pfizer Inc. Non-recombinant Coagulation Factors Product and Services
Table 56. Pfizer Inc. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Inc. Recent Developments/Updates
Table 58. Intas Biopharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Intas Biopharmaceuticals Ltd. Major Business
Table 60. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product and Services
Table 61. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Intas Biopharmaceuticals Ltd. Recent Developments/Updates
Table 63. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 64. Shandong Taibang Biological Products Major Business
Table 65. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product and Services
Table 66. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shandong Taibang Biological Products Recent Developments/Updates
Table 68. Sinopharm Group Shanghai Blood Products Basic Information, Manufacturing Base and Competitors
Table 69. Sinopharm Group Shanghai Blood Products Major Business
Table 70. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product and Services
Table 71. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sinopharm Group Shanghai Blood Products Recent Developments/Updates
Table 73. SHANGHAI RAAS Basic Information, Manufacturing Base and Competitors
Table 74. SHANGHAI RAAS Major Business
Table 75. SHANGHAI RAAS Non-recombinant Coagulation Factors Product and Services
Table 76. SHANGHAI RAAS Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. SHANGHAI RAAS Recent Developments/Updates
Table 78. China Resources Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. China Resources Boya Bio-Pharmaceutical Major Business
Table 80. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product and Services
Table 81. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. China Resources Boya Bio-Pharmaceutical Recent Developments/Updates
Table 83. Chengdu Rongsheng Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Chengdu Rongsheng Pharmaceuticals Major Business
Table 85. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product and Services
Table 86. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Chengdu Rongsheng Pharmaceuticals Recent Developments/Updates
Table 88. Yuanda Shuyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Yuanda Shuyang Pharmaceutical Major Business
Table 90. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product and Services
Table 91. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Yuanda Shuyang Pharmaceutical Recent Developments/Updates
Table 93. HUALAN BIO Basic Information, Manufacturing Base and Competitors
Table 94. HUALAN BIO Major Business
Table 95. HUALAN BIO Non-recombinant Coagulation Factors Product and Services
Table 96. HUALAN BIO Non-recombinant Coagulation Factors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. HUALAN BIO Recent Developments/Updates
Table 98. Global Non-recombinant Coagulation Factors Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Non-recombinant Coagulation Factors Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Non-recombinant Coagulation Factors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in Non-recombinant Coagulation Factors, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Non-recombinant Coagulation Factors Production Site of Key Manufacturer
Table 103. Non-recombinant Coagulation Factors Market: Company Product Type Footprint
Table 104. Non-recombinant Coagulation Factors Market: Company Product Application Footprint
Table 105. Non-recombinant Coagulation Factors New Market Entrants and Barriers to Market Entry
Table 106. Non-recombinant Coagulation Factors Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Non-recombinant Coagulation Factors Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Non-recombinant Coagulation Factors Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Non-recombinant Coagulation Factors Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Non-recombinant Coagulation Factors Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global Non-recombinant Coagulation Factors Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Non-recombinant Coagulation Factors Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Non-recombinant Coagulation Factors Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Non-recombinant Coagulation Factors Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global Non-recombinant Coagulation Factors Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Non-recombinant Coagulation Factors Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Non-recombinant Coagulation Factors Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Non-recombinant Coagulation Factors Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Non-recombinant Coagulation Factors Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Non-recombinant Coagulation Factors Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Non-recombinant Coagulation Factors Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Non-recombinant Coagulation Factors Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Non-recombinant Coagulation Factors Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Non-recombinant Coagulation Factors Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Non-recombinant Coagulation Factors Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Non-recombinant Coagulation Factors Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Non-recombinant Coagulation Factors Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Non-recombinant Coagulation Factors Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Non-recombinant Coagulation Factors Raw Material
Table 166. Key Manufacturers of Non-recombinant Coagulation Factors Raw Materials
Table 167. Non-recombinant Coagulation Factors Typical Distributors
Table 168. Non-recombinant Coagulation Factors Typical Customers
LIST OF FIGURE
s
Figure 1. Non-recombinant Coagulation Factors Picture
Figure 2. Global Non-recombinant Coagulation Factors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Type in 2022
Figure 4. Coagulation Factor VIII Examples
Figure 5. Human Fibrinogen Examples
Figure 6. Others Examples
Figure 7. Global Non-recombinant Coagulation Factors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Application in 2022
Figure 9. Hemophilia Examples
Figure 10. Fibrinogen Deficiency Examples
Figure 11. Other Examples
Figure 12. Global Non-recombinant Coagulation Factors Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Non-recombinant Coagulation Factors Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Non-recombinant Coagulation Factors Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Non-recombinant Coagulation Factors Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Non-recombinant Coagulation Factors by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Non-recombinant Coagulation Factors Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Non-recombinant Coagulation Factors Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Non-recombinant Coagulation Factors Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Non-recombinant Coagulation Factors Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Non-recombinant Coagulation Factors Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Non-recombinant Coagulation Factors Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Non-recombinant Coagulation Factors Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Non-recombinant Coagulation Factors Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Non-recombinant Coagulation Factors Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Non-recombinant Coagulation Factors Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Non-recombinant Coagulation Factors Consumption Value Market Share by Region (2018-2029)
Figure 54. China Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Non-recombinant Coagulation Factors Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Non-recombinant Coagulation Factors Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Non-recombinant Coagulation Factors Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Non-recombinant Coagulation Factors Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Non-recombinant Coagulation Factors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Non-recombinant Coagulation Factors Market Drivers
Figure 75. Non-recombinant Coagulation Factors Market Restraints
Figure 76. Non-recombinant Coagulation Factors Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors in 2022
Figure 79. Manufacturing Process Analysis of Non-recombinant Coagulation Factors
Figure 80. Non-recombinant Coagulation Factors Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
